|
|
Exchange: |
N/A |
Security
Type: |
Common |
Shares
Out: |
121,380,000 |
Market
Cap: |
N/A |
Last
Volume: |
0 |
Avg
Vol: |
0 |
52
Week Range: |
$0 - $0 |
|
Level
I Sector: |
N/A |
Level
II Sector: |
N/A |
Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
|
Company Profile Guardant Health is a precision oncology company focused on helping conquer cancer globally through use of its proprietary blood-based tests, data sets and analytics. Co. is engaged in the clinical liquid biopsy market with its Guardant360 and GuardantOMNI tests. Co.'s Guardant360 test is a molecular diagnostic test measuring a number of cancer-related genes and its GuardantOMNI test has a 500-gene panel, both of which analyze circulating tumor DNA in blood. In addition, Co. is developing tests from its LUNAR-1 program for minimal residual disease and recurrence detection in cancer survivors, and its LUNAR-2 program for early detection of cancer.
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
2,187 |
2,187 |
5,168 |
98,220 |
Total Buy Value |
$38,963 |
$38,963 |
$136,461 |
$2,585,297 |
Total People Bought |
1 |
1 |
1 |
2 |
Total Buy Transactions |
1 |
1 |
2 |
4 |
Total Shares Sold |
100 |
6,000 |
10,991 |
31,616 |
Total Sell Value |
$1,905 |
$157,493 |
$334,111 |
$1,291,105 |
Total People Sold |
1 |
2 |
2 |
3 |
Total Sell Transactions |
1 |
3 |
6 |
11 |
End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Talasaz Amirali |
Chairman, President and COO |
|
2020-05-04 |
4 |
OE |
$4.18 |
$56,158 |
D/D |
13,435 |
3,169,387 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-29 |
4 |
AS |
$80.11 |
$302,800 |
D/D |
(3,780) |
111,171 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-29 |
4 |
OE |
$4.18 |
$15,800 |
D/D |
3,780 |
114,951 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-29 |
4 |
AS |
$80.25 |
$3,482,294 |
D/D |
(43,351) |
3,155,952 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-29 |
4 |
OE |
$4.18 |
$4,347 |
D/D |
1,040 |
3,199,303 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-28 |
4 |
AS |
$80.02 |
$97,628 |
D/D |
(1,220) |
111,171 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-28 |
4 |
OE |
$4.18 |
$5,100 |
D/D |
1,220 |
112,391 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-28 |
4 |
AS |
$80.23 |
$1,049,573 |
D/D |
(13,082) |
3,198,263 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-28 |
4 |
OE |
$4.18 |
$1,313 |
D/D |
314 |
3,211,345 |
|
- |
|
Clark Ian T |
Director |
|
2020-04-27 |
4 |
AS |
$77.50 |
$41,695 |
D/D |
(538) |
1,302 |
|
- |
|
Clark Ian T |
Director |
|
2020-04-27 |
4 |
OE |
$4.18 |
$2,249 |
D/D |
538 |
1,840 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-23 |
4 |
AS |
$77.32 |
$386,615 |
D/D |
(5,000) |
111,171 |
|
- |
|
Wiley Michael J |
Chief Legal Officer |
|
2020-04-23 |
4 |
OE |
$4.18 |
$20,900 |
D/D |
5,000 |
116,171 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-20 |
4 |
AS |
$72.25 |
$745,235 |
I/I |
(10,270) |
3,139,971 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-20 |
4 |
AS |
$72.25 |
$198,028 |
D/D |
(2,729) |
71,060 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-20 |
4 |
OE |
$4.18 |
$11,407 |
D/D |
2,729 |
73,789 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-17 |
4 |
AS |
$72.57 |
$2,125,047 |
I/I |
(29,230) |
3,150,241 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-17 |
4 |
AS |
$72.57 |
$564,959 |
D/D |
(7,771) |
71,060 |
|
- |
|
Talasaz Amirali |
Chairman, President and COO |
|
2020-04-17 |
4 |
OE |
$4.18 |
$32,483 |
D/D |
7,771 |
78,831 |
|
- |
|
Eltoukhy Helmy |
Chief Executive Officer |
|
2020-04-17 |
4 |
AS |
$70.21 |
$1,116,739 |
D/D |
(15,904) |
3,174,980 |
|
- |
|
Eltoukhy Helmy |
Chief Executive Officer |
|
2020-04-16 |
4 |
AS |
$70.01 |
$14,001 |
D/D |
(200) |
3,190,884 |
|
- |
|
Eltoukhy Helmy |
Chief Executive Officer |
|
2020-04-14 |
4 |
AS |
$70.06 |
$189,241 |
D/D |
(2,701) |
3,191,084 |
|
- |
|
Clark Ian T |
Director |
|
2020-04-14 |
4 |
AS |
$70.00 |
$188,230 |
D/D |
(2,689) |
1,302 |
|
- |
|
Clark Ian T |
Director |
|
2020-04-14 |
4 |
OE |
$4.18 |
$11,240 |
D/D |
2,689 |
3,991 |
|
- |
|
Meresman Stanley J |
Director |
|
2020-04-13 |
4 |
AS |
$66.62 |
$632,890 |
D/D |
(9,500) |
1,302 |
|
- |
|
671 Records found
|
|
Page 18 of 27 |
|
|